The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category-Reference-Cited by-同舟云学术

The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category

Published:2024-05-17 Issue:7 Volume:38 Page:1617-1620
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Kotrova Michaela^ORCID,Fronkova Eva^ORCID,Svaton Michael^ORCID,Drandi Daniela,Schön Felix,Hoogeveen Patricia,Hancock Jeremy,Skotnicova Aneta,Schilhabel Anke,Eckert Cornelia,Clappier Emmanuelle,Cazzaniga Gianni^ORCID,Schäfer Beat W.^ORCID,van Dongen Jacques J. M.^ORCID,Ritgen Matthias,Pott Christiane^ORCID,van der Velden Vincent H. J.^ORCID,Trka Jan^ORCID,Brüggemann Monika^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41375-024-02265-z.pdf

Reference10 articles.

1. van der Velden VHJ, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER, et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia. 2007;21:604–11.

2. Fronkova E, Muzikova K, Mejstrikova E, Kovac M, Formankova R, Sedlacek P, et al. B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL. Bone Marrow Transpl. 2008;42:187–96.

3. Kotrova M, van der Velden VHJ, van Dongen JJM, Formankova R, Sedlacek P, Brüggemann M, et al. Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL. Bone Marrow Transpl. 2017;52:962–8.

4. van der Velden VHJ, Wijkhuijs JM, van Dongen JJM. Non-specific amplification of patient-specific Ig/TCR gene rearrangements depends on the time point during therapy: implications for minimal residual disease monitoring. Leukemia. 2008;22:641–4.

5. Schwinghammer C, Koopmann J, Chitadze G, Karawajew L, Brüggemann M, Eckert C. A new view on minimal residual disease quantification in acute lymphoblastic leukemia using droplet digital PCR. J Mol Diagn. 2022;24:856–66.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines;Leukemia;2024-05-14